Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells

International Journal of Developmental Neuroscience

Volumn 26, Issue 7, 2008, Pages 763-777

  Resende, R R ^a   Britto, L R G ^a   Ulrich, H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Calcium signalling; Neuronal differentiation; P19 embryonal carcinoma cells; Proliferation; Purinergic receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BROXURIDINE; CYCLOPIAZONIC ACID; ENOLASE; NESTIN; PURINERGIC P2X RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; THAPSIGARGIN; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EMBRYONAL CARCINOMA; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL PROLIFERATION; EMBRYONAL CARCINOMA STEM CELLS; EMBRYONIC INDUCTION; HUMANS; INOSITOL PHOSPHATES; INTERMEDIATE FILAMENT PROTEINS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; NEUROGENESIS; NEURONS; PHOSPHOPYRUVATE HYDRATASE; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2; STEM CELLS;

EID: 53049104154     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.07.008     Document Type: Article

References (69)

1. Agresti C., Meomartini M.E., Amadio S., Ambrosini E., Volonté C., Aloisi F., and Visentin S. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res. Brain Res. Rev. 48 (2005) 157-165
2. Arslan G., Filipeanu C.M., Irenius E., Kull B., Clementi E., Allgaier C., Erlinge D., and Fredholm B.B. P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells. Neuropharmacol. 39 (2000) 482-496
3. Arthur D.B., Akassoglou K., and Insel P.A. P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19138-19143
4. Bain G., Ray W.J., Yao M., and Gottlieb D.I. From embryonal carcinoma cells to neurons: the P19 pathway. Bioassays 16 (1994) 343-348
5. Bally-Cuif L., and Hammerschmidt M. Induction and patterning of neuronal development, and its connection to cell cycle control. Curr. Opin. Neurobiol. 13 (2003) 16-25
6. Bennett G.C., Ford A.P., Smith J.A., Emmett C.J., Webb T.E., and Boarder M.R. P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia. Br. J. Pharmacol. 139 (2003) 279-288
7. Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C., Alexander K.M., Park H.S., Yu H., Metzger R., Kowaluk E., Jarvis M.F., and van Biesen T. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376 (1999) 127-138
8. Bo X., Zhang Y., Nassar M., Burnstock G., and Schoepfer R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375 (1995) 129-133
9. Boarder M.R., and Hourani S.M.O. The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol. Sci. 19 (1998) 99-107
10. + channels by recombinant receptors. Br. J. Pharmacol. 138 (2003) 1-3
11. Boulter J., Oshea-Greenfield A., Duvoisin R.M., Connolly J.G., Wada E., Jensen A., Gardner D., Heineimann S., and Patrick J. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J. Biol. Chem. 265 (1990) 4472-4481
12. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Ver. 87 (2007) 659-797
13. Burnstock G. Purine and pyrimidine receptors. Cell. Mol. Life Sci. 64 (2007) 1471-1483
14. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27 (2006) 166-176
15. Burnstock G. Purinergic signalling. Br. J. Pharmacol. 147 (2006) S172-S181
16. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240 (2004) 301-304
17. Campbell K. Dorsal-ventral patterning in the mammalian telencephalon. Curr. Opin. Neurobiol. 13 (2003) 50-56
18. Cauley K., Marks M., Gahring L.C., and Rogers S.W. Nicotinic receptor subunits alpha 3, alpha 4, and beta 2 and high affinity nicotine binding sites are expressed by P19 embryonal cells. J. Neurobiol. 30 (1996) 303-314
19. Cheung K.K., Chan W.Y., and Burnstock G. Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures. Neuroscience 133 (2005) 937-945
20. Cockayne D.A., Hamilton S.G., Zhu Q.M., Dunn P.M., Zhong Y., Novakovic S., Malmberg A.B., Cain G., Berson A., and Kassotakis L. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407 (2000) 1011-1015
21. Collo G., North R.A., Kawashima E., Merlo-Pich E., Neidhart S., Surprenant A., and Buell G. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16 (1996) 2495-2507
22. da Silva R.L., Resende R.R., and Ulrich H. Alternative splicing of P2X6 receptors in developing mouse brain and during in vitro neuronal differentiation. Exp. Physiol. 92 (2007) 139-145
23. Dave S., and Mogul D.J. ATP receptor activation potentiates a voltage-dependent Ca channel in hippocampal neurons. Brain Res. 715 (1996) 208-216
24. Elmslie K.S. Calcium current modulation in frog sympathetic neurones: multiple neurotransmitters and G proteins. J. Physiol. 451 (1992) 229-246
25. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7 (2006) 423-436
26. Filippov A.K., and Brown D.A. Activation of nucleotide receptors inhibits high-threshold calcium currents in NG108-15 neuronal hybrid cells. Eur. J. Neurosci. 8 (1996) 1149-1155
27. Fumagalli M., Brambilla R., D'Ambrosi N., Volonte C., Matteoli M., Verderio C., and Abbracchio M.P. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 43 (2003) 218-230
28. Gallagher C.J., and Salter M.W. Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors. J. Neurosci. 23 (2003) 6728-6739
29. Gangemi R.M., Perera M., and Corte G. Regulatory genes controlling cell fate choice in embryonic and adult neural stem cells. J. Neurochem. 89 (2004) 286-306
30. Gourine A.V., Llaudet E., Dale N., and Spyer K.M. ATP is a mediator of chemosensory transduction in the central nervous system. Nature 436 (2005) 108-111
31. Hardy A.R., Conley P.B., Luo J., Benovic J.L., Poole A.W., and Mundell S.J. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105 (2005) 3552-3560
32. He M.L., Koshimizu T.A., Tomic M., and Stojilkovic S.S. Purinergic P2X(2) receptor desensitization depends on coupling between ectodomain and C-terminal domain. Mol. Pharmacol. 62 (2002) 1187-1197
33. Jones-Villeneuve E.M., McBurney M.W., Rogers K.A., and Kalnins V.I. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell. Biol. 94 (1982) 253-262
34. Khakh B.S., Burnstock G., Kennedy C., King B.F., North R.A., Seguela P., Voigt M., and Humphrey P.P. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 53 (2001) 107-118
35. Khakh B.S., Proctor W.R., Dunwiddie T.V., Labarca C., and Lester H.A. Allosteric control of gating and kinetics at P2X4 receptor channels. J. Neurosci. 19 (1999) 7289-7299
36. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 340-350
37. Lazarowski E.R., Paradiso A.M., Watt W.C., Harden T.K., and Boucher R.C. UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2599-2603
38. Le K.T., Babinski K., and Seguela P. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 18 (1998) 7152-7159
39. Levine J.M., and Flynn P. Cell surface changes accompanying the neural differentiation of an embryonal carcinoma cell line. J. Neurosci. 6 (1986) 3374-3384
40. Ling K.K., Siow N.L., Choi R.C., Ting A.K., Kong L.W., and Tsim K.W. ATP potentiates agrin-induced AChR aggregation in cultured myotubes: activation of RhoA in P2Y1 nucleotide receptor signaling at vertebrate neuromuscular junctions. J. Biol. Chem. 279 (2004) 31081-31088
41. Majumder P., Trujillo C.A., Lopes C.G., Resende R.R., Gomes K.N., Yuahasi K.K., Britto L.R.G., and Ulrich H. New insights of purinergic receptor signaling in neuronal differentiation, neuroprotection and brain disorders. Purinergic Signal. 3 (2007) 317-331
42. Martins A.H., Alves J.M., Trujillo C.A., Schwindt T.T., Barnabé G.F., Motta F.L.T., Guimarães A.O., Casarini D.E., Mello L.E., Pesquero J.B., and Ulrich H. Kinin-B2 receptor expression and activity during differentiation of embryonic neurospheres. Cytometry A 73 (2008) 361-368
43. Martins A.H., Resende R.R., Majumder P., Faria M., Casarini D.E., Tarnok A., Colli W., Pesquero J.B., and Ulrich H. Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. J. Biol. Chem. 280 (2005) 19576-19586
44. McBurney M.W., and Rogers B.J. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev. Biol. 89 (1982) 503-508
45. McBurney M.W., Reuhl K.R., Ally A.I., Nasipuri S., Bell J.C., and Craig J. Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. Neurosci. 8 (1988) 1063-1073
46. Meyer M.P., Clarke J.D., Patel K., Townsend-Nicholson A., and Burnstock G. Selective expression of purinoceptor cP2Y1 suggests a role for nucleotide signalling in development of the chick embryo. Dev. Dyn. 214 (1999) 152-158
47. Michel A.D., Grahames C.B., and Humphrey P.P. Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 562-571
48. Mishra S.K., Braun N., Shukla V., Fullgrabe M., Schomerus C., Korf H.W., Gachet C., Ikehara Y., Sevigny J., Robson S.C., and Zimmermann H. Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 133 (2006) 675-684
49. Molliver D.C., Cook S.P., Carlsten J.A., Wright D.E., and McCleskey E.W. ATP and UTP excite sensory neurons and induce CREB phosphorylation through the metabotropic receptor, P2Y2. Eur. J. Neurosci. 16 (2002) 1850-1860
50. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19 (1996) 13-18
51. North R.A., and Surprenant A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 563-580
52. Parnas D., Heldman E., Branski L., Feinstein N., and Linial M. Expression and localization of muscarinic receptors in P19-derived neurons. J. Mol. Neurosci. 10 (1998) 17-29
53. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Ver. 50 (1998) 413-492
54. Rathbone M.P., Middlemmis P., Gysbers J.W., Andrew C., Herman M.A., Reed J.K., Ciccarelli R., Di Iorio P., and Caciagli F. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59 (1999) 663-690
55. Ray W.J., and Gottlieb D.I. Expression of ionotropic glutamate receptor genes by P19 embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 197 (1993) 1475-1482
56. Resende R.R., Alves A.S., Britto L.R.G., and Ulrich H. Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells. Exp. Cell Res. 314 (2008) 1429-1443
57. Resende R.R., Gomes K.N., Adhikari A., Britto L.R.G., and Ulrich H. Mechanism of acetylcholine-induced calcium signaling during neuronal differentiation of P19 embryonal carcinoma cells in vitro. Cell Calcium 43 (2008) 107-121
58. Resende R.R., Majumder P., Gomes K.N., Britto L.R.G., and Ulrich H. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-d-aspartate-glutamate and acetylcholine receptors during neuronal differentiation. Neuroscience 146 (2007) 1169-1181
59. Rogers S.W., Mandelzys A., Deneris E.S., Cooper E., and Heinemann S. The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J. Neurosci. 12 (1992) 4611-4623
60. Scemes E., Duval N., and Meda P. Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J. Neurosci. 23 (2003) 11444-11452
61. Stoop R., Surprenant A., and North R.A. Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J. Neurophysiol. 78 (1997) 1837-1840
62. Tu M.T., Luo S.F., Wang C.C., Chien C.S., Chiu C.T., Lin C.C., and Yang C.M. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br. J. Pharmacol. 129 (2000) 1481-1489
63. Turetsky D.M., Huettner J.E., Gottlieb D.I., Goldberg M.P., and Choi D.W. Glutamate receptor-mediated currents and toxicity in embryonal carcinoma cells. J. Neurobiol. 24 (1993) 1157-1169
64. Ulrich H., and Majumder P. Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications. Cell Prolif. 39 (2006) 281-300
65. Vereb G., Feuerstein B.G., Hyun W.C., Fulwyler M.J., Balazs M., and Szollosi J. Biphasic calcium response of platelet-derived growth factor stimulated glioblastoma cells is a function of cell confluence. Cytometry A 67 (2005) 172-179
66. von Kügelgen I., and Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 362 (2000) 310-323
67. Weisman G.A., Wang M., Kong Q., Chorna N.E., Neary J.T., Sun G.Y., Gonzalez F.A., Seye C.I., and Erb L. Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol. Neurobiol. 31 (2005) 169-183
68. Xia S.L., Wang L., Cash M.N., Teng X., Schwalbe R.A., and Wingo C.S. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors. Am. J. Physiol. Renal. Physiol. 287 (2004) F204-F214
69. 2+ signaling pathways in mouse embryonic stem cells. Cell Calcium 36 (2004) 135-146